Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/3/26 12:28 | 2/2/26 | VIR | Health | BioPrd | Biological Products, (No Diag | Sato Vicki L | CA | D | 3 | S | -432 | 6.55 | 0 | -66 | 1,188 | D | ||||||||||||||||
12/3/25 16:30 | 12/1/25 | VIR | Health | BioPrd | Biological Products, (No Diag | Svf Endurance (Cayman) Ltd | E9 | T | 3 | S.m | -5,268 | 6.23 | 0 | -845 | 14,110 | I | ||||||||||||||||
11/18/25 14:47 | 11/17/25 | VIR | Health | BioPrd | Biological Products, (No Diag | O'Byrne Jason | CA | O | EVP,CFO | 1 | S | -38 | 5.56 | 0 | -7 | 111 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |